Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2017 Should Health Care Organizations Use Information Gleaned from Organization-Sponsored Patient Support Groups in Strategic Planning? Priya Nambisan, PhD The risks of misinformation being spread through online patient forums can be mitigated by communication strategies aimed at physicians and organizations. AMA J Ethics. 2017;19(11):1088-1095. doi: 10.1001/journalofethics.2017.19.11.ecas3-1711. Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601. Case and Commentary Nov 2017 What Should Leaders Do When Inefficiency Is Perceived as a Cost of Inclusivity in Strategic Planning Processes in Health Care? Aveena Kochar, MD and Alia Chisty, MS, MD Commentary by Aveena Kochar, MD, and Alia Chisty, MS, MD Co-creative teams can overcome conflict by drawing on quality improvement principles. AMA J Ethics. 2017;19(11):1081-1087. doi: 10.1001/journalofethics.2017.19.11.ecas2-1711. Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Case and Commentary Oct 2022 What Would It Mean for Health Care Organizations to Justly Manage Their Waste? Genevieve S. Silva and Cassandra Thiel, PhD Restructuring health care waste management involves making existing waste audit data transparent. AMA J Ethics. 2022;24(10):E934-943. doi: 10.1001/amajethics.2022.934. Case and Commentary Jan 2023 How Should Health Professions Educators and Organizations Desegregate Teaching and Learning Environments? Aisha James, MD, MEd and Katrina A. Armstrong, MD, MSCE Motivating health equity requires taking deliberate steps toward desegregating health care, especially in academic health centers. AMA J Ethics. 2023;25(1):E7-14. doi: 10.1001/amajethics.2023.7. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Nov 2017 Should Health Care Organizations Use Information Gleaned from Organization-Sponsored Patient Support Groups in Strategic Planning? Priya Nambisan, PhD The risks of misinformation being spread through online patient forums can be mitigated by communication strategies aimed at physicians and organizations. AMA J Ethics. 2017;19(11):1088-1095. doi: 10.1001/journalofethics.2017.19.11.ecas3-1711.
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601.
Case and Commentary Nov 2017 What Should Leaders Do When Inefficiency Is Perceived as a Cost of Inclusivity in Strategic Planning Processes in Health Care? Aveena Kochar, MD and Alia Chisty, MS, MD Commentary by Aveena Kochar, MD, and Alia Chisty, MS, MD Co-creative teams can overcome conflict by drawing on quality improvement principles. AMA J Ethics. 2017;19(11):1081-1087. doi: 10.1001/journalofethics.2017.19.11.ecas2-1711.
Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Case and Commentary Oct 2022 What Would It Mean for Health Care Organizations to Justly Manage Their Waste? Genevieve S. Silva and Cassandra Thiel, PhD Restructuring health care waste management involves making existing waste audit data transparent. AMA J Ethics. 2022;24(10):E934-943. doi: 10.1001/amajethics.2022.934.
Case and Commentary Jan 2023 How Should Health Professions Educators and Organizations Desegregate Teaching and Learning Environments? Aisha James, MD, MEd and Katrina A. Armstrong, MD, MSCE Motivating health equity requires taking deliberate steps toward desegregating health care, especially in academic health centers. AMA J Ethics. 2023;25(1):E7-14. doi: 10.1001/amajethics.2023.7.